IPLL provides guidance and legal advice to pharmaceutical, biotechnology, and medical device companies on matters at the intersection of FDA regulation and intellectual property. Our attorneys have extensive experience in advising companies on market protection strategies, data exclusivity, patent term restoration, transactions, licensing, and due diligence.
We also provide advice in these subsections:
• Agrochemicals
• Biodefense
• Biologics and Biosimilars
• Bioprocessing and Biofuels
• Chemical
• Life Science
• Molecular and Cell Biology
• Nanomedicine
• Nutraceuticals
• Pharmacogenomics
• Therapeutic Antibodies
• Vaccines
Our related practice areas include:
• Abbreviated New Drug Application (ANDA) Litigation
• Patents
• Patent Litigation
• Intellectual Property Litigation
• Strategic IP Counseling
